valproic acid has been researched along with phorbol 12,13-dibutyrate in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, G; Hawver, DB; Manji, HK; Potter, WZ; Wright, CB | 1 |
Allegri, M; Bianchi, MG; Bussolati, O; Chiu, M; Franchi-Gazzola, R; Reia, L; Sala, R; Uggeri, J | 1 |
2 other study(ies) available for valproic acid and phorbol 12,13-dibutyrate
Article | Year |
---|---|
Chronic sodium valproate selectively decreases protein kinase C alpha and epsilon in vitro.
Topics: Animals; Blotting, Western; Cell Membrane; Cytosol; Diglycerides; Glioma; Isoenzymes; Kinetics; Phorbol 12,13-Dibutyrate; Phosphatidylserines; Protein Kinase C; Rats; Tumor Cells, Cultured; Valproic Acid | 1994 |
Valproic acid induces the glutamate transporter excitatory amino acid transporter-3 in human oligodendroglioma cells.
Topics: 2',3'-Cyclic Nucleotide 3'-Phosphodiesterase; Anticonvulsants; Aspartic Acid; Cell Line, Tumor; Enzyme Inhibitors; Excitatory Amino Acid Transporter 3; Gene Expression Regulation, Neoplastic; Glial Fibrillary Acidic Protein; Humans; Oligodendroglioma; Phorbol 12,13-Dibutyrate; Protein Transport; Receptor, Platelet-Derived Growth Factor alpha; RNA, Messenger; Signal Transduction; Time Factors; Tritium; Tubulin; Valproic Acid | 2012 |